Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer

Babar,Nassar,Nie,Zhang,He,Yeung,Norris,Ogura,Muldoon,Chen,Libreros

DOI: https://doi.org/10.3390/metabo14060314

IF: 4.1

2024-05-31

Metabolites

Abstract:Acute inflammation is the body's first defense in response to pathogens or injury that is partially governed by a novel genus of endogenous lipid mediators that orchestrate the resolution of inflammation, coined specialized pro-resolving mediators (SPMs). SPMs, derived from omega-3-polyunstaturated fatty acids (PUFAs), include the eicosapentaenoic acid-derived and docosahexaenoic acid-derived Resolvins, Protectins, and Maresins. Herein, we review their biosynthesis, structural characteristics, and therapeutic effectiveness in various diseases such as ischemia, viral infections, periodontitis, neuroinflammatory diseases, cystic fibrosis, lung inflammation, herpes virus, and cancer, especially focusing on therapeutic effectiveness in respiratory inflammation and ischemia-related injuries. Resolvins are sub-nanomolar potent agonists that accelerate the resolution of inflammation by reducing excessive neutrophil infiltration, stimulating macrophage functions including phagocytosis, efferocytosis, and tissue repair. In addition to regulating neutrophils and macrophages, Resolvins control dendritic cell migration and T cell responses, and they also reduce the pro-inflammatory cytokines, proliferation, and metastasis of cancer cells. Importantly, several lines of evidence have demonstrated that Resolvins reduce tumor progression in melanoma, oral squamous cell carcinoma, lung cancer, and liver cancer. In addition, Resolvins enhance tumor cell debris clearance by macrophages in the tumor's microenvironment. Resolvins, with their unique stereochemical structure, receptors, and biosynthetic pathways, provide a novel therapeutical approach to activating resolution mechanisms during cancer progression.

biochemistry & molecular biology

What problem does this paper attempt to address?

This paper attempts to explore the value of lipid metabolism in cancer research and treatment, with special attention to the role of Specialized Pro - Resolving Mediators (SPMs) in inflammation, infection and cancer. SPMs are a new class of endogenous lipid mediators derived from Omega - 3 polyunsaturated fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and they play a crucial role in the resolution of acute inflammation. These mediators include Resolvins, Protectins and Maresins, etc. They accelerate the resolution of inflammation by reducing excessive neutrophil infiltration, stimulating macrophage functions (such as phagocytosis, efferocytosis and tissue repair), controlling dendritic cell migration and T - cell responses, and reducing the production of pro - inflammatory cytokines.

In addition, the paper also emphasizes the therapeutic effects of SPMs in a variety of diseases, including ischemia, viral infection, periodontitis, neuroinflammatory diseases, cystic fibrosis, pulmonary inflammation, herpes virus and cancer, especially in the treatment of respiratory system inflammation and ischemia - related injuries. In particular, Resolvins have been shown to reduce tumor progression in melanoma, oral squamous cell carcinoma, lung cancer and liver cancer, and exert their anti - tumor effects by enhancing the clearance of tumor cell debris in the tumor microenvironment by macrophages.

In conclusion, this paper aims to evaluate the potential of SPMs as a new treatment method to activate the resolution mechanism during cancer progression.